Eradication of Therapy-resistant Human Prostate Tumors Using an Ultrasound-guided Site-specific Cancer Terminator Virus Delivery Approach
Open Access
- 1 February 2010
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 18 (2), 295-306
- https://doi.org/10.1038/mt.2009.252
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Ad-MDA-7; INGN 241: a review of preclinical and clinical experienceExpert Opinion on Biological Therapy, 2008
- Current status of experimental therapeutics for prostate cancerCancer Letters, 2008
- Autocrine regulation of mda -7/IL-24 mediates cancer-specific apoptosisProceedings of the National Academy of Sciences of the United States of America, 2008
- Prostate cancerThe Lancet, 2008
- Secretable Chaperone Grp170 Enhances Therapeutic Activity of a Novel Tumor Suppressor, mda-7/IL-24Cancer Research, 2008
- Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): Novel gene therapeutic for metastatic melanomaToxicology and Applied Pharmacology, 2007
- mda-7 in Combination with Bevacizumab Treatment Produces a Synergistic and Complete Inhibitory Effect on Lung Tumor XenograftMolecular Therapy, 2007
- Unique Conditionally Replication Competent Bipartite Adenoviruses—Cancer Terminator Viruses (CTV): Efficacious Reagents for Cancer Gene TherapyCell Cycle, 2006
- Local and Systemic Inhibition of Lung Tumor Growth After Nanoparticle-Mediatedmda-7/IL-24Gene DeliveryDNA and Cell Biology, 2004
- Local and Systemic Inhibition of Lung Tumor Growth After Nanoparticle-Mediated mda-7/IL-24 Gene DeliveryDNA and Cell Biology, 2004